annual meeting program - American Society of Clinical Oncology

Monday, June 7, 2010
Brd. 41D Vanderbilt Head and Neck Symptom Survey Version 2.0 (VHNSS 2.0): A tool
for the study of long-term oral health consequences of therapy for head and
neck cancer (HNC). (Abstract #9055)
E. Cooperstein, J. B. Epstein, B. A. Murphy, M. S. Dietrich, J. Gilbert
Brd. 41E Visual analog scale (VAS) and time trade-off (TTO) preferences for side
effects (SE) of chemoradiation (chemoXRT): A comparison of patients (pts)
and caregivers (CG). (Abstract #9056)
D. C. Bodurka, A. Jhingran, L. M. Ramondetta, P. J. Eifel, C. H. Crane, A. T. Phan,
D. Urbauer, M. M. Frumovitz, L. S. Elting, C. C. Sun
Brd. 41F Assessing the magnitude of antiemetic benefit with the addition of the NK1
receptor antagonist (NK1) aprepitant for all platinum agents: Analysis of
1,872 patients (pts) in prospective randomized clinical phase III trials (RCTs).
(Abstract #9057)
R. J. Gralla, B. L. Rapoport, K. Jordan, J. C. Street, A. Carides
Brd. 41G The impact of bone health on endocrine treatment strategy in older adults
with early-stage, hormone receptor–positive breast cancer. (Abstract #9058)
S. K. Pal, A. Hurria, L. Wong, A. Naeim
Brd. 41H Expectations of benefit and symptom burdens among advanced cancer
patients (ACP) and spousal caregivers during the course of phase I trials.
(Abstract #9059)
F. J. Hlubocky, T. G. Sher, K. Wroblewski, E. Luzar, M. J. Ratain, C. Daugherty
Brd. 42A Refinement of the patient-reported outcomes version of the common
terminology criteria for adverse events (PRO-CTCAE) via cognitive
interviewing. (Abstract #9060)
J. Hay, T. M. Atkinson, T. R. Mendoza, B. B. Reeve, G. Willis, J. J. Gagne,
A. P. Abernethy, C. S. Cleeland, D. Schrag, E. M. Basch
Brd. 42B Predicting cisplatin-induced ototoxicity in testicular germ cell cancer.
(Abstract #9061)
J. G. Monzon, L. Brunham, C. K. Kollmannsberger, N. Murray, A. J. Attwell,
C. Ross, T. Wong, B. Carleton, M. Hayden, K. A. Gelmon
Brd. 42C Timing of palliative care referral and symptom burden in phase I cancer
patients: A retrospective cohort study. (Abstract #9062)
H. A. Parsons, D. Hui, L. Nguyen, S. L. Palla, J. Liu, S. Yennurajalingam,
R. Kurzrock, E. Bruera
Brd. 42D Evaluation of axillary node dissection on measures of upper-extremity
disability and overall quality of life after breast cancer surgery.
(Abstract #9063)
S. A. McLaughlin, A. S. Parker, N. N. Diehl, M. Arnold, J. H. Nguyen, E. A. Perez
Brd. 42E Mini-Cog: A brief screening tool for cognitive impairment in older cancer
patients. (Abstract #9064)
M. S. Thein, I. S. Browner, C. Klein, M. Binner, G. R. Shapiro
Brd. 42F Changes in symptoms and inpatient mortality among advanced cancer
patients admitted to a palliative care unit in a comprehensive cancer center.
(Abstract #9065)
M. Mori, H. A. Parsons, M. De la Cruz, A. F. Elsayem, S. L. Palla, J. Liu, Z. Li,
J. L. Palmer, E. Bruera, N. A. Fadul
Brd. 42G Retrospective mortality comparisons of cancer patients with sepsis
syndromes. (Abstract #9066)
D. Joyce, V. Holly, R. Dukes, E. Trueblood
Brd. 42H Cancer care on a continuum: Maintaining fertility after diagnosis and
treatment. (Abstract #9067)
J. M. Knopman, J. A. Grifo, P. A. Labella, N. Noyes
Brd. 43A Use of thermal sensation as a biomarker of response to palliative
radiotherapy for cancer-induced bone pain. (Abstract #9068)
A. C. Scott, B. J. Laird, H. I. Wan, S. M. Fleetwood-Walker, R. Mitchell,
G. D. Murray, L. A. Colvin, M. T. Fallon
379
MONDAY